Track topics on Twitter Track topics that are important to you
Peptor's mission is to become a leading developer of drugs for the specific treatment of autoimmune diseases. The company has targeted Diabetes, Rheumatoid Arthritis and other autoimmune diseases that lack curative treatment.
Peptor's competitive edge is based on a proprietary technology platform which enables the manipulation of a key player in the immune system - Heat Shock Protein 60 (hsp60). The drugs being developed by the company consist of synthesized compounds known as SCAPLs (Small Cyclic Analogs of Protein Loops), which switch off various immune system patterns associated with hsp60. Each drug is designed to influence the immune system in a different way and specifically treat an autoimmune disease without affecting the rest of the body's systems.
Peptor's mission is to become a leading developer of drugs for the specific treatment of autoimmune diseases. The company has targeted Diabetes, Rheumatoid Arthritis and other autoimmune diseases that...
We have published hundreds of Peptor news stories on BioPortfolio along with dozens of Peptor Clinical Trials and PubMed Articles about Peptor for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Peptor Companies in our database. You can also find out about relevant Peptor Drugs and Medications on this site too.
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...